BioCentury
ARTICLE | Company News

Dr. Reddy's, GlaxoSmithKline deal

December 6, 2010 8:00 AM UTC

GlaxoSmithKline will transfer ownership of its penicillin manufacturing site in Bristol, Tenn., and U.S. rights to Augmentin amoxicillin/clavulanate and Amoxil amoxicillin to Dr. Reddy's. GSK will ret...